B BRAUN MEDICAL INC vs Sanofi-Aventis Deutschland GmbH: FDA Enforcement Comparison

B BRAUN MEDICAL INC has been the subject of 22 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Sanofi-Aventis Deutschland GmbH.

B BRAUN MEDICAL INC: 0 warning letters, 22 recalls, 0 approval records, 0 Form 483s.

Sanofi-Aventis Deutschland GmbH: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Side by side

B BRAUN MEDICAL INC — Warning letters0

Sanofi-Aventis Deutschland GmbH — Warning letters0

B BRAUN MEDICAL INC — Recalls22

Sanofi-Aventis Deutschland GmbH — Recalls0

B BRAUN MEDICAL INC — Approval records0

Sanofi-Aventis Deutschland GmbH — Approval records0

B BRAUN MEDICAL INC — Form 483s0

Sanofi-Aventis Deutschland GmbH — Form 483s1

Timeline

B BRAUN MEDICAL INC

Most recent FDA action: June 10, 2026

Full history →

Sanofi-Aventis Deutschland GmbH

Most recent FDA action: January 16, 2025

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"B BRAUN MEDICAL INC vs Sanofi-Aventis Deutschland GmbH: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/b-braun-medical-inc-vs-sanofi-aventis-deutschland-gmbh

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗